More than 650 people have undergone cryosuspension, freezing their bodies in the hope that future scientific advancements will allow them to be revived. In addition, around 300 pets are also expected to be preserved using cryogenic methods when the technology becomes available. Globally, over 5,400 individuals have already made arrangements to be frozen, reflecting a growing interest in cryonics as a potential path to defying death. Cryonics involves preserving the body at extremely low temperatures to halt biological decay, buying time until medical science can potentially restore life. This practice highlights the intersection of technology, mortality, and futuristic science.

The process typically begins the moment legal death is declared, as "cryonauts" are placed in vitrification chambers where their blood is replaced with specialized anti-freeze agents to prevent ice crystal formation, which would otherwise shred cellular structures. These patients are then stored in liquid nitrogen-filled dewar flasks at temperatures as low as -196 degrees Celsius. Proponents of the field argue that "death" is a sliding scale rather than a binary event, suggesting that today’s terminal patients are simply "early" for a future cure.

However, the field remains deeply controversial, hovering on the edge of mainstream science. Critics point to the immense energy requirements of maintaining these facilities for centuries and the currently insurmountable challenge of repairing brain tissue at the molecular level. Despite these hurdles, the rise in "standby" contracts indicates a profound shift in how humanity views the end of life—not as an inevitable conclusion, but as a biological problem that might one day be solved by nanotechnology and advanced reanimation. For many, the exorbitant cost of the procedure is a small price to pay for even a one-percent chance at a second life in a distant, more advanced era.